All Diabetes articles
-
Independent professional body guidelineCaReMeUK cardiovascular risk optimisation algorithm
A guide for non-diabetes specialist physicians and primary care teams for cardiovascular risk optimisation in patients with type 2 diabetes and atherosclerotic cardiovascular disease
-
Supplement
Dipeptidyl peptidase-4 inhibitors—still a major player in type 2 diabetes care
This promotional supplement has been commissioned and funded by Boehringer Ingelheim Ltd and developed in partnership with Guidelines.
View Trajenta® (linagliptin) prescribing and adverse event reporting information
PC-GB-103452 Date of preparation: January 2021 -
Supplement
Dipeptidyl peptidase-4 inhibitors—still a major player in type 2 diabetes care
This promotional supplement has been commissioned and funded by Boehringer Ingelheim Ltd and developed in partnership with Guidelines for Nurses.
View Trajenta® (linagliptin) prescribing and adverse event reporting information
PC-GB-103453 Date of preparation: January 2021 -
Video
Identification of pancreatic exocrine insufficiency (PEI) in patients with diabetes
In this video, Su Down looks at the identification of PEI in patients with diabetes.
This video has been commissioned and funded by Viatris and developed in partnership with Guidelines. Information intended for UK healthcare professionals only.
NON-2020-3287 December 2020 -
Video
Assessment of pancreatic exocrine insufficiency (PEI) in primary care
In this video, Professor Michael Cummings looks at the assessment of PEI in patients with diabetes.
This video has been commissioned and funded by Viatris and developed in partnership with Guidelines. Information intended for UK healthcare professionals only.
NON-2020-3288 December 2020 -
Video
Management of pancreatic exocrine insufficiency (PEI) in primary care
In this video, Professor Michael Cummings looks at the management of PEI in patients with diabetes.
This video has been commissioned and funded by Viatris and developed in partnership with Guidelines. Information intended for UK healthcare professionals only.
NON-2020-3289 December 2020 -
NICE guideline
NICE diabetes in pregnancy guideline
An up-to-date summary of NICE guidance on diabetes management in pregnancy. Includes gestational diabetes, preconception, antenatal, and postnatal care.
-
NICE guideline
NICE type 1 diabetes guideline
This summary on type 1 diabetes in adults covers diagnosis, insulin therapy, and blood glucose management, and includes a useful algorithm
-
NICE guideline
NICE type 2 diabetes in children guideline
This succinct Guidelines summary advises on the appropriate diagnosis and management of type 2 diabetes mellitus in children and young people.
-
NICE guideline
NICE type 1 diabetes in children guideline
This summary includes recommendations on pharmacological therapy, and recognition and management of diabetic ketoacidosis.
-
NICE guideline
NICE type 2 diabetes guideline
This summary provides recommendations on blood glucose targets, patient education, and includes a useful algorithm on blood glucose management
-
Independent professional body guideline
KDIGO guideline on diabetes management in CKD
Recommendations on comprehensive care, glycaemic monitoring and targets, lifestyle and antihyperglycaemic interventions, and approaches to self-management and optimal models of care
-
NHS guideline
NHS guideline for delivering diabetes care during COVID-19
This NHS guidance for general practice covers the key points of delivering diabetes care during the challenging times of the COVID-19 pandemic
-
Independent professional body guideline
PCDE pharmacological management of type 2 diabetes
This succinct summary highlights the treatment recommendations for type 2 diabetes by cardiovascular/renal disease or risk factor.
-
Information
ClinOwl: a new resource for healthcare professionals
ClinOwl is a new content discovery platform for healthcare professionals, delivering the latest clinical articles from the leading medical journals in a single view Browse and search over 18,000 articles organised across 40+ clinical specialties and sub-specialties. You can also sign up to ...
-
Independent professional body guideline
Type 2 diabetes pharmacological management pathway comparison
This comparison table summarises recommendations on the management of hyperglycaemia in adults with type 2 diabetes from ADA/EASD, NICE, and SIGN
-
NICE guideline
Diabetic foot problems: prevention and management
This summary covers preventing and managing foot problems in children, young people and adults with diabetes. It aims to reduce variation in practice, including antibiotic prescribing for diabetic foot infections.
-
Working party guideline/algorithm
Guideline for the managed introduction of biosimilar basal insulin
This guideline was developed by a multidisciplinary expert panel: Down S et al with the support of an educational grant from Mylan.
-
Feature article
A top tips guide to biosimilar insulins
Karen Bartha shares her top tips on prescribing considerations for biosimilars such as stability, interchangeability/switching, and brand names.
-
Feature article
Safer insulin prescribing and ongoing management of individuals taking insulin in primary care
Karen Bartha discusses recommendations for the safe prescribing of insulin and the types of insulin available for different patient groups.
![20200212 Guidelines comparison tablev10 [online] UPDATED 2020 v4](https://d3j7puhwqgd8ts.cloudfront.net/Pictures/100x67//9/3/4/6934_20200212guidelinescomparisontablev10onlineupdated2020v4_419801.png)
